We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

53 hedge funds and large institutions have $3.94M invested in Envoy Medical Warrant in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

7% less funds holding

Funds holding: 5753 (-4)

55% less capital invested

Capital invested by funds: $8.83M → $3.94M (-$4.89M)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
53
Holders Change
-4
Holders Change %
-7.02%
% of All Funds
0.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
8
Reduced
8
Closed
6
Calls
$7.17M
Puts
Net Calls
+$7.17M
Net Calls Change
+$511K
Name Holding Trade Value Shares
Change
Change in
Stake
PI
51
PEAK6 Investments
Illinois
$2K
LA
52
Linden Advisors
New York
-$298K -382,563 Closed
HHAM
53
HITE Hedge Asset Management
Massachusetts
-$242K -306,913 Closed
ICMH
54
Integrity Capital Management (HK)
Hong Kong
-$39K -50,000 Closed
KPF
55
K2 Principal Fund
Ontario, Canada
-$39K -50,000 Closed
EC
56
EJF Capital
Virginia
-$8K -10,000 Closed
CS
57
Clear Street
New York
-$1K -1,174 Closed

COCHW Hedge Fund Activity: Q1 2022 in Review

53 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q1 2022, worth a combined $3.94M — down 55% from $8.83M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of COCHW and 2 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Woodline Partners, adding an estimated $28.7K. The largest seller was Linden Advisors, exiting entirely with an estimated $298K sold.

  • 53 institutional investors held Envoy Medical Warrant (COCHW) as of Q1 2022, down from 57 in Q4 2021.
  • Funds reported $3.94M of Envoy Medical Warrant stock for Q1 2022, down 55% quarter-over-quarter.
  • 2 funds opened new Envoy Medical Warrant positions in Q1 2022 and 6 closed out, a net change of -4 holders.
  • The largest Envoy Medical Warrant buyer in Q1 2022 was Woodline Partners, an estimated $28.7K added.
  • The largest Envoy Medical Warrant seller in Q1 2022 was Linden Advisors, an estimated $298K sold.

Based on aggregated 13F filings for Q1 2022.